Dr. Reena Thomas received her medical degree from Georgetown University School of Medicine in Washington, DC and her PhD in Molecular Immunology from the City of Hope Graduate School in Duarte, California. She completed her training as a resident in Neurology as well as her fellowship training in Neuro-Oncology at Stanford Health Care. Over the last decade as a faculty member at Stanford, Dr. Thomas has focused her research on immune based cancer therapies of glioblastoma brain tumors and the use of novel machine learning techniques for MRI biomedical data fusion to accelerate non-invasive personalized medicine. Her pioneering work has resulted in the development of a first-in-human phase 1 clinical trial to assess the safety of Chimeric Antigen Receptor (CAR)-T cell immunotherapy for patients with glioblastoma and a newly developed pipeline for adult brain tumor patients to be treated at Stanford Health Care with CAR T cell therapy. This trial established the first solid tumor CAR T therapy program at Stanford Health Care and has been awarded a $12 million grant over the next 4 years. Dr. Thomas holds multiple senior leadership roles at the Stanford School of Medicine as Associate Dean of Diversity in Medical Education and Vice Chair in the Department of Neurology. On a national level, Dr. Thomas chairs committees in both the Society of Neuro Oncology and American Academy of Neurology.